Literature DB >> 32630109

Case Report of an Injectional Anthrax in France, 2012.

Jean-Marc Thouret1, Olivier Rogeaux1, Emmanuel Beaudouin1, Marion Levast1, Vincent Ramisse2, Fabrice V Biot3,4, Eric Valade3,5,6, François Thibault3, Olivier Gorgé3,4, Jean-Nicolas Tournier3,4,6.   

Abstract

(1) Background: Bacillus anthracis is a spore-forming, Gram-positive bacterium causing anthrax, a zoonosis affecting mainly livestock. When occasionally infecting humans, B. anthracis provokes three different clinical forms: cutaneous, digestive and inhalational anthrax. More recently, an injectional anthrax form has been described in intravenous drug users. (2) Case presentation: We report here the clinical and microbiological features, as well as the strain phylogenetic analysis, of the only injectional anthrax case observed in France so far. A 27-year-old patient presented a massive dermohypodermatitis with an extensive edema of the right arm, and the development of drug-resistant shocks. After three weeks in an intensive care unit, the patient recovered, but the microbiological identification of B. anthracis was achieved after a long delay. (3) Conclusions: Anthrax diagnostic may be difficult clinically and microbiologically. The phylogenetic analysis of the Bacillus anthracis strain PF1 confirmed its relatedness to the injectional anthrax European outbreak group-II.

Entities:  

Keywords:  drug-user; injectional anthrax; outbreak; phylogeny

Year:  2020        PMID: 32630109     DOI: 10.3390/microorganisms8070985

Source DB:  PubMed          Journal:  Microorganisms        ISSN: 2076-2607


  1 in total

Review 1.  Antibodies against Anthrax Toxins: A Long Way from Benchlab to the Bedside.

Authors:  Arnaud Avril; Jean-Nicolas Tournier; Jean-Charles Paucod; Bénédicte Fournes; Philippe Thullier; Thibaut Pelat
Journal:  Toxins (Basel)       Date:  2022-02-25       Impact factor: 4.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.